Rankings
▼
Calendar
EDIT Q3 2025 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena
EDIT
Editas Medicine, Inc.
$256M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
+12265.6% YoY
Gross Profit
$8M
100.0% margin
Operating Income
-$25M
-325.4% margin
Net Income
-$25M
-333.0% margin
EPS (Diluted)
$-0.28
QoQ Revenue Growth
+110.8%
Cash Flow
Operating Cash Flow
-$31M
Free Cash Flow
-$31M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$202M
Total Liabilities
$188M
Stockholders' Equity
$13M
Cash & Equivalents
$166M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$61,000
+12265.6%
Gross Profit
$8M
-$2M
+590.4%
Operating Income
-$25M
-$66M
+62.6%
Net Income
-$25M
-$62M
+59.6%
Revenue Segments
Reportable Segment
$8M
100%
← FY 2025
All Quarters